x
Filter:
Filters applied
- JLR Patient-Oriented and Epidemiological Research
- inflammationRemove inflammation filter
- Journal of Lipid ResearchRemove Journal of Lipid Research filter
Publication Date
Please choose a date range between 2015 and 2019.
Author
- Abhishek, Abhishek1
- Adorni, Maria Pia1
- Akintoye, Emmanuel1
- Alamuddin, Naji1
- Bai, Xue1
- Barochia, Amisha V1
- Barrett, David A1
- Berthold, Heiner K1
- Bunn, Janice Y1
- Buxton, Orfeu M1
- Calabresi, Laura1
- Cederholm, Tommy1
- Cejkova, Sona1
- Chaemsaithong, Piya1
- Chaiworapongsa, Tinnakorn1
- Chang, Anne-Marie1
- Chapman, Victoria1
- Choy, David F1
- Christensen, Erin S1
- Crain, Karen I1
- Cuento, Rosemarie A1
- Docheva, Nikolina1
- Doherty, Michael1
- Ebenstein, David B1
- Edin, Matthew L1
Keyword
- diet and dietary lipids3
- eicosanoids3
- fatty acid3
- nutrition3
- arachidonic acid2
- atherosclerosis2
- lipidomics2
- lipids2
- omega-3 fatty acids2
- acute phase response1
- Alzheimer's disease1
- amyloid β1
- apolipoproteins1
- asthma1
- campesterol1
- cholesterol absorption1
- cholesterol biosynthesis1
- cholesterol efflux1
- clinical studies1
- clinical trials1
- cytokines1
- dehydrogenases1
- docosahexaenoic acid1
- HDL structure1
JLR Patient-Oriented and Epidemiological Research
12 Results
- Patient-Oriented and Epidemiological ResearchOpen Access
Four nights of sleep restriction suppress the postprandial lipemic response and decrease satiety
Journal of Lipid ResearchVol. 60Issue 11p1935–1945Published online: September 4, 2019- Kelly M. Ness
- Stephen M. Strayer
- Nicole G. Nahmod
- Margeaux M. Schade
- Anne-Marie Chang
- Gregory C. Shearer
- and others
Cited in Scopus: 9Chronic sleep restriction, or inadequate sleep, is associated with increased risk of cardiometabolic disease. Laboratory studies demonstrate that sleep restriction causes impaired whole-body insulin sensitivity and glucose disposal. Evidence suggests that inadequate sleep also impairs adipose tissue insulin sensitivity and the NEFA rebound during intravenous glucose tolerance tests, yet no studies have examined the effects of sleep restriction on high-fat meal lipemia. We assessed the effect of 5 h time in bed (TIB) per night for four consecutive nights on postprandial lipemia following a standardized high-fat dinner (HFD). - Patient-Oriented and Epidemiological ResearchOpen Access
Omega-6 oxylipins generated by soluble epoxide hydrolase are associated with knee osteoarthritis
Journal of Lipid ResearchVol. 59Issue 9p1763–1770Published online: July 9, 2018- Ana M. Valdes
- Srinivasarao Ravipati
- Petros Pousinis
- Cristina Menni
- Massimo Mangino
- Abhishek Abhishek
- and others
Cited in Scopus: 25Omega-6 FAs are inflammatory mediators that are increased in joints with osteoarthritis (OA), but their association with OA progression is not yet well defined. To investigate the relationship between omega-6 FAs and knee OA, we measured with LC-MS the levels of 22 omega-6 lipids (arachidonic acid, linoleic acid, and 20 oxylipins) in synovial fluid (SF) from 112 knees of 102 individuals (58 with knee OA; 44 controls). We hypothesized that oxylipin metabolites would increase in OA knee SF and with radiographically progressive disease. - Patient-Oriented and Epidemiological ResearchOpen Access
Plasma cholesterol homeostasis, HDL remodeling and function during the acute phase reaction
Journal of Lipid ResearchVol. 58Issue 10p2051–2060Published online: August 22, 2017- Francesca Zimetti
- Stefano De Vuono
- Monica Gomaraschi
- Maria Pia Adorni
- Elda Favari
- Nicoletta Ronda
- and others
Cited in Scopus: 36Acute phase reaction (APR) is a systemic inflammation triggered by several conditions associated with lipid profile alterations. We evaluated whether APR also associates with changes in cholesterol synthesis and absorption, HDL structure, composition, and cholesterol efflux capacity (CEC). We analyzed 59 subjects with APR related to infections, oncologic causes, or autoimmune diseases and 39 controls. We detected no difference in markers of cholesterol synthesis and absorption. Conversely, a significant reduction of LpA-I- and LpAI:AII-containing HDL (−28% and −44.8%, respectively) and of medium-sized HDL (−10.5%) occurred in APR. - Patient-Oriented and Epidemiological ResearchOpen Access
High density lipoproteins and type 2 inflammatory biomarkers are negatively correlated in atopic asthmatics
Journal of Lipid ResearchVol. 58Issue 8p1713–1721Published online: June 27, 2017- Amisha V. Barochia
- Elizabeth M. Gordon
- Maryann Kaler
- Rosemarie A. Cuento
- Patricia Theard
- Debbie M. Figueroa
- and others
Cited in Scopus: 19Blood eosinophil counts and serum periostin levels are biomarkers of type 2 inflammation. Although serum levels of HDL and apoA-I have been associated with less severe airflow obstruction in asthma, it is not known whether serum lipids or lipoprotein particles are correlated with type 2 inflammation in asthmatics. Here, we assessed whether serum lipids and lipoproteins correlated with blood eosinophil counts or serum periostin levels in 165 atopic asthmatics and 163 nonasthmatic subjects with and without atopy. - Patient-Oriented and Epidemiological ResearchOpen Access
The relationship between non-HDL cholesterol and macrophage phenotypes in human adipose tissue
Journal of Lipid ResearchVol. 57Issue 10p1899–1905Published online: August 1, 2016- Rudolf Poledne
- Ivana Kralova Lesna
- Anna Kralova
- Jiri Fronek
- Sona Cejkova
Cited in Scopus: 14Data from experimental animal models and in vitro studies suggest that both hyperlipoproteinemia and obesity predispose to development of proinflammatory pathways of macrophages within adipose tissue. The aim of this study was to analyze whether non-HDL cholesterol concentration in healthy living kidney donors (LKDs) is related to the number and phenotype of proinflammatory macrophages in visceral and subcutaneous adipose tissue. Adipose tissue samples were collected by cleansing the kidney grafts of LKDs obtained peroperatively. - Patient-Oriented and Epidemiological ResearchOpen Access
Clinical chorioamnionitis at term: the amniotic fluid fatty acyl lipidome
Journal of Lipid ResearchVol. 57Issue 10p1906–1916Published online: August 18, 2016- Krishna Rao Maddipati
- Roberto Romero
- Tinnakorn Chaiworapongsa
- Piya Chaemsaithong
- Sen-Lin Zhou
- Zhonghui Xu
- and others
Cited in Scopus: 33Clinical chorioamnionitis at term (TCC) is the most common obstetrical infliction diagnosed in labor and delivery units worldwide and is associated with a substantial increase in maternal and neonatal morbidity and mortality. This obstetrical complication is a heterogeneous condition, as only half of patients have detectable microorganisms in the amniotic cavity. Because bioactive lipids play a key role in the initiation and resolution of an inflammatory response, we aimed to characterize the amniotic fluid lipidome in patients with TCC. - Patient-Oriented and Epidemiological ResearchOpen Access
Effect of fish oil on monoepoxides derived from fatty acids during cardiac surgery
Journal of Lipid ResearchVol. 57Issue 3p492–498Published online: January 9, 2016- Emmanuel Akintoye
- JasonH.Y. Wu
- Tao Hou
- Xiaoling Song
- Jun Yang
- Bruce Hammock
- and others
Cited in Scopus: 6Our objective was to assess the dynamics of monoepoxides derived from polyunsaturated fatty acids (MEFAs), and their response to n-3 PUFA supplementation, in the setting of acute tissue injury and inflammation (cardiac surgery) in humans. Patients (479) undergoing cardiac surgery in three countries were randomized to perioperative fish oil (EPA + DHA; 8–10 g over 2–5 days preoperatively, then 2 g/day postoperatively) or placebo (olive oil). Plasma MEFAs derived from n-3 and n-6 PUFAs were measured 2 days postoperatively. - Patient-Oriented and Epidemiological ResearchOpen Access
Cytochrome P450-derived epoxyeicosatrienoic acids and coronary artery disease in humans: a targeted metabolomics study
Journal of Lipid ResearchVol. 57Issue 1p109–119Published online: November 10, 2015- Akinyemi Oni-Orisan
- Matthew L. Edin
- John Andrew Lee
- Michael A. Wells
- Erin S. Christensen
- Kimberly C. Vendrov
- and others
Cited in Scopus: 45Cytochrome P450 (CYP)-derived epoxyeicosatrienoic acids (EETs) exhibit potent cardiovascular protective effects in preclinical models, and promoting the effects of EETs has emerged as a potential therapeutic strategy for coronary artery disease (CAD). The relationship between circulating EET levels and CAD extent in humans, however, remains unknown. A panel of free (unesterified) plasma eicosanoid metabolites was quantified in 162 patients referred for coronary angiography, and associations with extent of CAD [no apparent CAD (N = 39), nonobstructive CAD (N = 51), and obstructive CAD (N = 72)] were evaluated. - Patient-Oriented and Epidemiological ResearchOpen Access
Increased palmitate intake: higher acylcarnitine concentrations without impaired progression of β-oxidation
Journal of Lipid ResearchVol. 56Issue 9p1795–1807Published online: July 8, 2015- C.Lawrence Kien
- Dwight E. Matthews
- Matthew E. Poynter
- Janice Y. Bunn
- Naomi K. Fukagawa
- Karen I. Crain
- and others
Cited in Scopus: 5Palmitic acid (PA) is associated with higher blood concentrations of medium-chain acylcarnitines (MCACs), and we hypothesized that PA may inhibit progression of FA β-oxidation. Using a cross-over design, 17 adults were fed high PA (HPA) and low PA/high oleic acid (HOA) diets, each for 3 weeks. The [1-13C]PA and [13-13C]PA tracers were administered with food in random order with each diet, and we assessed PA oxidation (PA OX) and serum AC concentration to determine whether a higher PA intake promoted incomplete PA OX. - Patient-Oriented and Epidemiological ResearchOpen Access
Bioactive products formed in humans from fish oils
Journal of Lipid ResearchVol. 56Issue 9p1808–1820Published online: July 15, 2015- Carsten Skarke
- Naji Alamuddin
- John A. Lawson
- Xuanwen Li
- Jane F. Ferguson
- Muredach P. Reilly
- and others
Cited in Scopus: 72Resolvins, maresins, and protectins can be formed from fish oils. These specialized pro-resolving mediators (SPMs) have been implicated in the resolution of inflammation. Synthetic versions of such SPMs exert anti-inflammatory effects in vitro and when administered to animal models. However, their importance as endogenous products formed in sufficient amounts to exert anti-inflammatory actions in vivo remains speculative. We biased our ability to detect SPMs formed in healthy volunteers by supplementing fish oil in doses shown previously to influence blood pressure and platelet aggregation under placebo-controlled conditions. - Patient-Oriented and Epidemiological ResearchOpen Access
IL-6 blockade by monoclonal antibodies inhibits apolipoprotein (a) expression and lipoprotein (a) synthesis in humans
Journal of Lipid ResearchVol. 56Issue 5p1034–1042Published online: January 21, 2015- Nike Müller
- Dominik M. Schulte
- Kathrin Türk
- Sandra Freitag-Wolf
- Jochen Hampe
- Rainald Zeuner
- and others
Cited in Scopus: 97Lipoprotein (a) [Lp(a)] is a highly atherogenic lipid particle. Although earlier reports suggested that Lp(a) levels are mostly determined by genetic factors, several recent studies have revealed that Lp(a) induction is also caused by chronic inflammation. Therefore, we aimed to examine whether cytokine blockade by monoclonal antibodies may inhibit Lp(a) metabolism. We found that interleukin 6 (IL-6) blockade by tocilizumab (TCZ) reduced Lp(a) while TNF-α-inhibition by adalimumab in humans had no effect. - Patient-Oriented and Epidemiological ResearchOpen Access
Effects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: the OmegAD study
Journal of Lipid ResearchVol. 56Issue 3p674–681Published online: January 23, 2015- Xiuzhe Wang
- Erik Hjorth
- Inger Vedin
- Maria Eriksdotter
- Yvonne Freund-Levi
- Lars-Olof Wahlund
- and others
Cited in Scopus: 59Specialized proresolving mediators (SPMs) induce resolution of inflammation. SPMs are derivatives of n-3 and n-6 PUFAs and may mediate their beneficial effects. It is unknown whether supplementation with PUFAs influences the production of SPMs. Alzheimer's disease (AD) is associated with brain inflammation and reduced levels of SPMs. The OmegAD study is a randomized, double-blind, and placebo-controlled clinical trial on AD patients, in which placebo or a supplement of 1.7 g DHA and 0.6 g EPA was taken daily for 6 months.